Status:
UNKNOWN
Revascularization After Transcatheter Aortic Valve Implantation (REVIVAL)
Lead Sponsor:
San Luigi Gonzaga Hospital
Conditions:
Transcatheter Valve Implantation
TAVI
Eligibility:
All Genders
18+ years
Brief Summary
Evaluate incidence, clinical indications, and feasibility of PCI performed after TAVI.
Detailed Description
The increasing operator experience combined with an improved performance of devices have led to extend current transcatheter aortic valve implantation (TAVI) indications to patients at low or intermed...
Eligibility Criteria
Inclusion
- Any patient undergoing PCI after TAVI, irrespective of clinical indications and irrespective of whether planned or not at the time of TAVI
Exclusion
- none
Key Trial Info
Start Date :
April 20 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2017
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03283501
Start Date
April 20 2017
End Date
December 31 2017
Last Update
September 14 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Humanitas Research Hospital, Humanitas University
Rozzano, Milan, Italy
2
Interventional Unit, San Luigi Gonzaga University Hospital, Orbassano, and Rivoli Hospital, Turin, Italy
Turin, Italy, 10100
3
Hospital Clinico San Carlos
Madrid, Spain